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Prevalence and correlates of psychological
distress symptoms among patients
with substance use disorders in drug
rehabilitation centers in urban Nepal:
a cross-sectional study
Bishal Gyawali1,2*, Bishnu P. Choulagai3, Damaru Prasad Paneru4, Meraj Ahmad5, Anja Leppin6 and Per Kallestrup1
Abstract
Background: The burden of substance misuse in developing countries is large and increasing, with negative
consequences for physical and psychological health. Substance use disorders and psychological distress commonly
co-exist, however few studies have examined this relationship in developing countries, including Nepal. Our aim was to
investigate the prevalence of psychological distress symptoms and associated factors among patients with substance
use disorders attending drug rehabilitation centers in Nepal.
Methods: We conducted a cross-sectional study including 180 patients attending drug rehabilitation centers in the
Kathmandu Valley region of Nepal. We used the 6-item Kessler scale (K6) to measure symptoms of psychological
distress, and data on socio-demographics, behavioral and psychosocial factors. Multivariable analyses were used to
identify factors associated with distress.
Results: The prevalence of high psychological distress symptoms among patients with substance use disorder
was 51.1 %. The mean score found on the K6 was 12.22 (SD = 5.87). Outcomes of multivariable analyses demonstrated
various factors associated with symptoms of psychological distress, including age (β = −0.122, 95 % CI = −0.218; −0.026),
education (β =2.694, 95 % CI = 0.274; 5.115), severity of drug abuse (Drug Abuse Screening Test-10-DAST10)(β = 0.262,
95 % CI = 0.022;0.502), and family functioning (Adaptability, Partnership, Growth, Affection and Resolve-APGAR)
(β = −0.525, 95 % CI = −0.787; −0.264).
Conclusions: High psychological distress symptoms are common in patients with substance use disorder in
Nepal. Demographics (age, education), behavioral (drug abuse severity), and psychosocial factors (family functionality)
were associated with psychological distress symptoms. If confirmed by future longitudinal studies such characteristics
may assist in identifying groups at risk for co-morbid psychological distress symptoms among patients with substance
use disorders. Future treatment approaches for substance use disorders should address co-existing mental illness
in Nepal.
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Background
Substance use disorders (SUDs), according to DSM-5,
refer to a problematic pattern of use of alcohol or
another substance causing clinically significant impair-
ment in daily life or noticeable distress. These disorders
are prevalent worldwide and may lead to a wide range of
physical, psychological and emotional health problems.
SUDs are often associated with considerable psychiatric
disorders, including depression and anxiety [1]. Various
epidemiological [2, 3] as well as clinic based [4, 5] studies
from Western countries have reported a high prevalence
of comorbidity of SUDs and psychiatric disorders. Mental
disorders and SUDs were one of the leading causes of
disease burden in 2010 accounting for 7.4 % of global
Disability-Adjusted Life Years (DALYs) and 22.9 % of
global Years Lived with Disability (YLDs) [6]. This is a
particular challenge for developing countries where the
burden of mental health and SUDs is predicted to increase
[6] but which-due to resource restrictions and limited
prioritization in health care planning and workforce
development-often face problems in fully addressing these
problems. This is also the case for Nepal. Data about
prevalence of mental health problems in population
groups with SUDs are limited. However, a recent study of
188 consecutively admitted alcohol use disorder (AUD)
patients in treatment facilities in Kathmandu found the
lifetime and 12-month prevalence rates of major depres-
sion to be 45 and 36 % respectively [7]. In another
smaller-scale cross-sectional study of alcohol-dependent
patients in Eastern Nepal, 38 out of 60 patients (63.3 %)
had one or more psychiatric disorders [8].
This substantial level of psychiatric comorbidity raises
concern since depression and anxiety may not only
influence help-seeking behavior, such as obtaining diag-
nosis and treatment for SUDs [9] as well as adherence
to treatment [10]; they may decrease quality of life [11],
increase risk of relapse [12], of social isolation [13] and
risk of early mortality [14]. Risk factors for depression
and anxiety among SUD patients in Western countries
have been reported to be female gender [15], younger
age, low family income and being single [16].
In Nepal, mental health risk factors in groups with
SUDs have so far rarely been investigated. However,
Neupane et al. in a study of 188 Nepalese patients being
treated for AUDs reported that a main factor to be asso-
ciated with major depression was not being married [7].
A similar finding was also reported by an earlier small-
scale study by Pradhan et al. [17]. Further, coming from
an urban as compared to a rural area and living in a
nuclear family compared to a joint or extended family
were positively associated with risk of depression while
age, gender, education and income were unrelated [7].
However, there is a general paucity of information re-
garding potential behavioral and psychosocial correlates
of psychological distress, and particularly regarding the
factors, which potentially mediate associations between
socio-demographic characteristics and mental health
for instance, stress experience, or familial functionality.
Thus, while family type and marital status have been
reported to be relevant [7, 17], quality of family rela-
tionships might be just as or even more important. A
study conducted in India, for instance, reported associ-
ations between poor relationships with family, poor
physical health, experiences of violence and sexual
abuse with depression and anxiety [18]. Another factor,
which might be relevant in the socio-cultural context of
Nepal, is the stigma involved in substance use/abuse.
Neupane et al. in a study on treatment seeking for alco-
hol problems in Nepal found considerable differences
in searching for treatment depending on whether alco-
hol consumption was considered a social taboo or not
[19]. Similarly, it might be expected that patients who
see themselves as socially stigmatized by being treated
for substance abuse in a clinic might be more likely to
experience psychological distress.
Despite the publication of some studies highlighting
the high levels of psychiatric disorders in patients with
SUDs, there continues to be a dearth of evidence exam-
ining the associated factors of psychological distress in
SUDs, especially in the Nepalese socio-cultural context.
A greater understanding of the specific factors associated
with psychological distress among patients with SUDs is
however necessary to develop appropriate and effective
interventions. The aim of this study is to investigate the
prevalence of psychological distress symptoms and associ-
ated factors among patients with substance use disorders
attending drug rehabilitation centers in Nepal.
Methods
Study design, population and setting
This was a cross sectional study using convenience
sampling technique. Data were collected between March
and July 2014 in seven drug and alcohol rehabilitation
centers in Kathmandu Valley of Nepal. These centers
provided a therapeutic environment for detoxification of
patients with SUDs. The Kathmandu Valley has a popu-
lation of approximately 2.5 million, the majority of who
are Hindus and Buddhists, while Muslims and Christians
are religious minorities [20] Ethnic and caste groups
comprise Dalits, disadvantaged and relatively advantaged
Janajatis, disadvantaged non-Dalits, religious minori-
ties, and upper caste groups [21]. The literacy rate in
Kathmandu is 86.3 %, and Nepali is the most widely
spoken language [20]. Mental health care is provided
to some extent at the outpatient mental health facilities,
although private clinics and clinics funded by Non-
Government Organizations (NGOs) also exist [22]. Only
few NGOs/private organizations in urban areas run
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rehabilitation services that include therapeutic detoxifica-
tion and 12-step programs. At the time of the study, each
rehabilitation center was providing care for between 30
and 90 patients.
Data collection tools
Data on demographics, socio-economic conditions, be-
havioral (alcohol abuse severity and drug abuse severity),
psychosocial factors (stressful life events, perceived stigma,
and family functionality) and psychological distress symp-
toms were collected using a self-administered question-
naire. Prior to questionnaire development, an extensive
literature review was conducted to identify associated
factors for psychological distress.
We used a standardized questionnaire to collect socio-
demographic information, including age, gender, ethnicity,
marital status, education, occupation, monthly income
and living situation. Age and monthly income were
assessed as continuous variables. Ethnicity was grouped
into three categories (Upper caste, Janajati and Others).
Marital status was dichotomized into married and un-
married. Education was grouped into three categories
(primary, secondary and university). Occupation was
dichotomized into employed and unemployed. Living
situation was dichotomized into living alone and with
family. Stressful life events were defined as whether or
not any serious personal or emotional problem had
occurred during the past 12 months (no/yes).
We used the Kessler-6 (K6) Psychological Distress
Scale to measure distress symptoms, a standardized and
validated screening tool for non-specific psychological
distress, including depression and anxiety [23]. The K6
offers the advantage of being a broader screening tool
compared to some of the other locally validated mental
health screens such as the General Health Questionnaire-
12 (GHQ-12), and Patients Health Questionnaire-9
(PHQ-9), because it is not specific to a single disorder and
has been validated to screen for common disorders in de-
veloping country settings [24]. The scale is available in a
Nepali version [25] and has been used previously in Nepal
[26], as well as in a variety of cultural settings in different
parts of the world [27, 28]. The K6 uses a Likert scale to
establish how often an individual has experienced psycho-
logical distress over the preceding 30 days. Scores range
from 0 to 24 with higher score indicating better outcomes.
A K6 score of greater than 12 has been defined as indi-
cating high psychological distress [29]. Psychological
distress assessment was performed on the seventh day
after patients’ admission to the rehabilitation center.
We assessed participants’ risk of alcohol abuse using
the Alcohol Use Disorder Identification Test (AUDIT), a
10-item screening measure designed to identify drinkers
at risk for alcohol abuse or dependence [30]. Scores
ranged from 0 to 40: 0–7 indicates low risk; 8–15
indicates moderate risk or hazardous drinking; 16–19
indicates high-risk or harmful drinking; and a score of
20 or above indicates possible dependence [30].
Drug use was measured using the Drug Abuse Screening
Test-10 (DAST-10), which quantitatively assesses the se-
verity of drug-related problems. A single summary score
reflects the number of drug abuse items endorsed. A score
ranging from 1 to 2 indicates low risk, 3–5 indicates
moderate severity level, 6–8 indicates a substantial level
and a score ranging from 9 to 10 indicates a severe
level of problems [31].
We used the Perceived Stigma of Substance Abuse
Scale (PSAS) which is an eight item self rated scale to
look at stigma experienced by the substance users due to
their substance use [32]. All items are marked on a
Likert-type scale with four options (‘totally disagree’ to
‘totally agree’). Six of the eight items are reverse scored.
The scale ranges from 8 to 12, higher scores indicating
presence of perceived stigma. Luoma et al. developed
and validated the scale which is easy to administer and
has shown a good face and construct validity and an ac-
ceptable internal consistency [32].
Perceived family functionality was measured by the
Adaptability, Partnership, Growth, Affection and Resolve
(APGAR) Scale, which comprises questions about key
components of family function [33]. A score of 7 to 10
suggests a highly functional family, a score of 4 to 6 sug-
gest a moderately dysfunctional family and a score of 0
to 3 suggests a severely dysfunctional family.
Procedure
Three specially trained research assistants with a health
professional background carried out the administration
of the questionnaires in training rooms available in each
center. The research assistants introduced themselves at
first and then briefly explained the purpose of the study.
Subsequently, an informed consent form was distributed
to all eligible participants and later collected. Eligible
participants were patients undergoing residential treat-
ment for SUDs, including alcohol abuse and drug abuse
who were 16 years or above, and able to read and write
in Nepali. Those who were reluctant to participate in the
study and who had cognitive impairments were excluded
from the study. Presence of cognitive impairment was
assessed by asking patients whether they had ever been
diagnosed by a physician as having memory problems.
In case of any literacy difficulty, the consent form was
read aloud. The consent form informed participants
about the purpose of the study and advised that partici-
pation was voluntary. Participants were assured verbally
and on paper that all information provided would be
kept strictly confidential and not used except for the
study purpose. All participants who agreed to participate
were provided an informed consent form to sign. After
Gyawali et al. BMC Psychiatry  (2016) 16:314 Page 3 of 10
obtaining a written informed consent, the research assis-
tants distributed the self-administered questionnaires
and offered necessary instructions for the participants to
fill it out anonymously. The study protocol received
ethical approval from the Manipal College of Medical
Sciences, Pokhara, Nepal.
Statistical analysis
We conducted descriptive analyses to identify charac-
teristics of the study sample. We analyzed the K6 data
as a continuous outcome. Analyses of associated factors
were conducted in two stages: i) the association of each
variable with distress was assessed through univariate
linear regression models; ii) multivariate analyses were
carried out in the second stage among variables that
showed an association at p < 0.05 in the first stage. To
guide these multivariable analyses, we used an analytical
framework based on hierarchical relationships of factors
associated with Psychological Distress Symptoms Fig. 1.
This approach enabled us to take account of hierarchical
relationships between predictors, and balance reliance on
statistically significant associations [34]. Furthermore, we
arranged associated factors into three levels: the top level
consisted of socio-demographic factors, which we con-
sidered to act directly, or indirectly through intermedi-
ate factors to cause distress; the next level included
behavioral factors; the lowest level included psycho-social
factors as the most proximal predictors. Correlation ana-
lyses and t-tests were used to identify significant factors
associated with psychological distress. Reliability was
assessed with Cronbach’s alpha [35]. All statistical analyses
were conducted using Statistical Package for Social
Science 22.0 (SPSS 22.0) software [36].
According to the framework, groups of variables were
entered in hierarchical order into a multivariable modeling
procedure. A similar approach has been used previously
to assess predictors of common mental disorders [37, 38].
The assumptions of linear regression (outliers, normality
of distribution and linearity) were checked (using box plot,
histogram, q-q plot and scatter plot). Tolerances for the
parameter estimates were examined to assure that multi-
collinearity was not a problem.
Results
All of the 180 participants completed and returned the
questionnaire. Socio-demographic characteristics of par-
ticipants are summarized in Table 1. The study popula-
tion was mostly males (85.6 %) and the mean age of the
participants was 29.08 years (SD ± 9.98). More than half
of participants (51.7 %) belonged to Upper Caste Groups
and 54 % were unmarried. More than 52 % of the partici-
pants were unemployed. Nearly 88 % were living with
family. The average monthly income of participant’s house-
hold was Rupees 23,030.60 (SD ± 8628.54) or 230.31 US
Dollars (1 Nepali Rupees = 0.01 US Dollar, July 2014). The
mean DAST score was 5.42 points (SD = 3.918). The
internal consistency of the DAST scale was found to
be α =0.86. The mean AUDIT score was 17.03 points
(SD = 12.078) and Cronbach’s alpha for the scale was
0.85. The mean on the perceived stigma scale was
24.32 points (SD = 5.095). Internal consistency of the
stigma scale was α = 0.72. The mean APGAR score
was 5.69 points (SD = 2.907). The internal consistency
of the APGAR scale was α = 0.84. The K6 score distri-
bution was approximating a normal distribution with
a mean score of 12.22 and standard deviation (SD) of
5.87. The mean K6 score for male and female partici-
pants were 11.84 ± 5.91 and 14.42 ± 5.18 respectively.
The internal consistency of the K6 was Cronbach’s
alpha = 0.89. The overall prevalence of high psycho-
logical distress symptoms among participants was
51.1 % (n = 92).
Univariate correlational analyses and t-tests were per-
formed initially between individual K-6 scale scores and
three types of variables: socio-demographic variables (age,
gender, ethnicity, marital status, education, occupation,
living situation, and monthly income), behavioral variables
(severity of substance abuse: scores on DAST and AUDIT)
and psychosocial variables (stressful life events, perceived
stigma, and scores on APGAR) (Table 2). We found
Exposures
Outcome 
Socio-demographic factors
Gender
Age
Ethnicity
Marital status
Education
Occupation
Monthly income
Living situation
Behavioral factors
Drug abuse severity
Alcohol abuse severity
Psychosocial factors
Stressful life events
Perceived stigma
Family function
Psychological Distress Symptoms
Fig. 1 An analytical conceptual framework of associated factors for
psychological distress symptoms
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significant correlations and t-test differences between the
K6 scores and age, gender, marital status, education, score
on DAST, perceived stigma, and APGAR.
We, then, performed hierarchical multiple regression
analyses with those socio-demographic variables, be-
havioral variables, and psychosocial variables that had
been significant in the univariate analyses as predictors
and the K-6 score as the dependent variable (Table 3).
The socio-demographic variables age, gender, marital
status, and education were entered into the first block
and accounted for 13.4 % of the variance in K6 scores
[F (4,175) = 6.788]. The second block included the
DAST score and explained an additional 4.1 % of the vari-
ance [F (5,174) =7.383]. Block three added perceived stigma
and the APGAR score and explained an additional 8.7 % of
the variance [F (7,172) =8.728].
Summary statistics for the complete model are pre-
sented in Table 4. The final regression model accounted
for a significant 26.2 % of the explained variance in K6
score [F (7,172) =10.14].
Age (β = −0.12; 95 % CI −0.218, −0.026; p = 0.013) and
education (β = 2.694; 95 % CI = 0.274, 5.115, p = 0.029)
were the only socio-demographic variables that were sig-
nificant predictors in this model. In addition, scores on
the DAST (β = 0.262; 95 % CI = 0.022, 0.502; p = 0.032)
and the APGAR (β = −0.525; 95 % CI = −0.787, −0.264;
p < 0.001) were significantly related to the K6 score in
the complete model.
Discussion
The present results show that 51.1 % of patients being
treated for SUDs in Kathmandu Valley treatment centers
experienced high psychological distress symptoms. As
expected this rate is considerably above those found in
community settings for the general population of Nepal,
where studies have reported psychological distress rates
from 9.8 % [39] to 33.7 % [40]. Two other studies have
specifically reported distress data for patients treated for
SUDs in Nepal, one reporting lower, the other considerably
higher distress prevalence. In the study by Neupane et al.
only 51 (30.2 %) out of 169 patients with AUD had recently
experienced depressive symptoms as measured by the
Hopkins Symptoms Check List-25 [37] and 36 % had
Table 2 Univariate analysis of K6 scores in relation to
socio-demographic characteristics, behavioral characteristics,
and psychosocial characteristics
N = 180 M or n % or SD t r P-value
Socio-demographic characteristics
Age (years) 29.08 9.981 −0.3 p < 0.001
Female 26 (14.4 %) 1.99 0.048
Upper Caste 93 (51.7 %) 1.127 0.256
Unmarried 97 (53.9 %) 2.031 0.044
Primary education 20 (11.1 %) 2.226 0.027
Unemployed 95 (52.8 %) 1.776 0.078
Monthly income 23,030.60 8628.54 - 0.39 0.700
Living alone 22 (12.2 %) 1.247 0.313
Behavioral characteristics
Alcohol abuse severity 17.03 12.078 0.127 0.136
Drug abuse severity 5.42 3.918 0.391 p < 0.001
Psychosocial characteristics
Stressful life events 116 (64.4 %) 0.703 0.483
Perceived stigma 24.32 5.095 0.339 p < 0.001
Family functionality 5.69 2.907 0.315 p < 0.001
Note: t observed t value, r correlation, P significance level
Table 1 Sample characteristics
Characteristics M or n % or SD
Age 29.08 9.981
Gender
Male 154 85.6
Female 26 14.4
Ethnicity
Upper caste 93 51.7
Janajati 82 45.6
Others 5 2.8
Marital status
Married 83 46.1
Unmarried 97 53.9
Education
Primary 20 11.1
Secondary 114 63.3
University 46 25.6
Occupation
Employed 85 47.2
Unemployed 95 52.8
Living situation
Alone 22 12.2
With family 158 87.8
Stressful life events
Yes 116 64.4
No 64 35.6
Monthly income (Rupees) 23,030.60 8628.54
Drug abuse severity (DAST-10) 5.42 3.918
Alcohol abuse severity (AUDIT) 17.03 12.078
Perceived stigma 24.32 5.095
Family functioning (APGAR) 5.69 2.907
Note: M mean, n group size, SD standard deviation, DAST-10 drug abuse
screening test-10, AUDIT alcohol use disorder identification test; APGAR adaptability,
partnership, growth, affection and resolve
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experienced at least one major depressive episode
assessed by the WHO’s Composite International Diag-
nostic Interview in the preceding 12 months [7]. A
main factor explaining the discrepancy between preva-
lence rates in the two studies may lie in the different
time window for distress prevalence estimation. While
the present study assessed distress at the end of the
first week of treatment asking for experience in the pre-
ceding four weeks, the study by Neupane et al. assessed
symptoms during the preceding two weeks excluding
the week post-admission, since the later is specifically
stressful, difficult and often painful period. Including
distress ratings from this period may, due to their tran-
sitory nature, lead to overestimation of longer-term dis-
tress experience. Further, the present study included
slightly higher proportions of younger respondents who
are known to report higher distress rates [37, 41].
Another study from Nepal by Pradhan et al., including
53 patients treated from AUD, found as many as 94.3 %
of patients suffering from depressive symptoms as mea-
sured by the Hamilton Depression Rating Scale [17].
This extremely high rate is explained by the fact that
the study included only patients who had been admitted
to the psychiatric ward of the hospital with the diagnosis
of mental or behavioral disorder due to alcohol use.
Comparisons with prevalence data from other countries
also show a wide range of distress rates. Comparable
findings to those of the present study where reported
by a Jamaican study of 56 patients treated for SUDs
[42], where 42.8 % reported severe or very severe de-
pression symptoms on the Kessler-10- scale and a study
from Hunan Province, China, where 43 % of heroin-
dependent patients in a treatment center showed depres-
sive symptoms and 53 % anxiety symptoms as assessed by
the Zung’s Self-Rating Depression (SDS)/Self-Rating
Anxiety Scales (SAS) [43].
In contrast, much higher prevalence rates were re-
ported by a Norwegian study, which found that 83 % of
185 in patients treated for alcohol and other drug abuse,
scored above the cut-off for the Hopkins Symptoms
Checklist-10 [44]. Distress prevalence was assessed for
the week prior to treatment admission, a period, where
psychological problems might culminate. Armstrong et al.
in a study on 420 drug injecting male users participating
in needle-and syringe programs in Delhi, India also found
extremely high rates of 84 % of participants with depres-
sive and 71 % with anxiety symptoms measured by the
PHQ-9 [18]. In this case the study population was con-
siderably more socially disadvantaged than the present
study, with high proportions being illiterate, homeless
and living with very small income/being dependent on
scavenging.
For the present study it might be argued that given the
timing and reference period for distress assessment, the
prevalence rate particularly reflects the intensely stress-
ful phases before entering treatment and early days of
treatment, this overestimating distress levels in terms of
a longer-term and more stable experience in need of
psychiatric/psychological treatment. Despite this caveat,
proportions of patients suffering from psychological co-
morbidity are sizeable. And while it remains unclear to
which extent development of SUDs and/or being in
treatment for SUDs causes distress or prior distress and
depression contribute to self-medication via substance
use, the findings indicate a need for action, since these
conditions, if left untreated are likely to increase the risk of
poor health outcomes, of relapse after treatment, workplace
productivity loss and even premature mortality [45, 46].
Our study also investigated a set of socio-demographic,
behavioral, and psychosocial factors that may be import-
ant to consider in understanding the development of psy-
chological distress symptoms among this population. In
particular, we found that family functioning as measured
by the APGAR-Scale was significantly negatively associ-
ated with the K6 distress score. Prior studies conducted in
Western and Eastern countries have also reported that
family dysfunction is strongly associated with mental dis-
orders [47, 48]. Few studies, however, have so far provided
support for the association between family functioning
Table 3 A hierarchical multiple regression analysis of determinants of K6-scores: contributions of each variable block to changes in R2
Determinants R2 Δ R2 F df ΔF Sig ΔF
Block 1 Socio-demographics 0.134 0.134 6.788 4,175 6.788 p < 0.001
Block 2 Behavioral 0.175 0.041 8.587 5,174 7.383 0.004
Block 3 Psychosocial 0.262 0.087 10.148 7,172 8.728 p < 0.001
Note: R2, F and df describe the overall regression equation after each block has been entered into the model. ΔR2, ΔF, and significance ΔF describe the
contributions of each individual block
Table 4 Multivariate analysis of K6 scores
Determinants β (95 % CI) SE P-value
Age −0.122 (−0.218; −0.026) 0.049 0.013
Female 1.206 (−0.983; 3.394) 1.109 0.278
Unmarried −0.610 (−2.421; 1.202) 0.918 0.507
Primary education 2.694 (0.274; 5.115) 1.226 0.029
Drug abuse severity 0.262 (0.022; 0.502) 0.122 0.032
Family functionality −0.525 (−0.787; −0.264) 0.132 p < 0.001
Note: β regression coefficient, CI confidence interval, SE standard error
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and psychiatric comorbidity in Nepal [49] and India [50].
A study by Krishnakumar et al. [51] in India revealed that
sources of distress in the family could be parental deaths,
inter-parental conflicts, unfulfilled needs and wants, mental
illness, parental substance addiction, parental divorce and
disharmony. That the family history of substance abuse
might be a relevant factor, was also shown in a study by
Neupane et al. with Nepalese patients being treated for
AUD and where reported that parental problem drinking
was related to major depression in social groups where
alcohol consumption was considered taboo [7]. Deficits in
family functioning may lead to experience of distress
and subsequent increase in substance use. Moreover,
Hosseinbor et al. found that individuals who do not
have an intimate and supportive relationship within their
family are more likely to be attracted by and inclined to-
wards friends and groups of their own age and become
more susceptible to using drugs in the social context of
these peer groups, which again later may cause psycho-
logical problems [52].
Vice versa SUDs in a family member will very likely
affect the family system and family relations in a nega-
tive way so that conflicts arise and relations deteriorate
over time. Shyangwa et al. in a study on the families of
patients with opium dependence syndrome in New Delhi
showed that 75 % of patients’ spouses perceived a severe
burden due to their husband’s opioid dependence [53].
This study further demonstrated that having only pri-
mary education is associated with more psychological
distress symptoms. This finding is consistent with the
previous studies [54, 55]. People with less education may
feel socially trapped and helpless and might experience
more adverse situations which could directly contribute
to the emergence of psychological distress [56]. Further,
patients with lower educational attainment may have
lesser knowledge and poorer coping skills to deal with
their substance abuse problem and thereby increase psy-
chological distress and poor quality of life.
Also, age was a significant and negative correlate of
psychological distress symptoms suggesting that as age
increases, the level of psychological distress decreases.
This is supported by another study conducted in Nepal,
investigating recent depressive symptoms in AUD pa-
tients [37]. In general, young age is an unstable period in
life when one may be less able to deal with daily stress
while coping with developmental tasks, particularly when
during puberty major physical an psychological changes
are experienced [37, 46]. Evidence also shows that family
disputes and domestic violence in Nepal place youngsters
at greater risk of distress [57]. Furthermore, age also affect
distress via severity of drug use since drug use was highest
in the younger group and severity of drug use was again
associated with distress. The association between psy-
chological distress and age underscores the need for
detection, assessment and treatment of mental health
problems at early ages among patients with SUDs.
Finally, this study found that drug use severity as
measured by the DAST-10 was significantly positively
associated with psychological distress symptoms as also
reported elsewhere [44]. Higher drug consumption may
lead to higher levels of compromised physical health,
negative social consequences as well as self-esteem prob-
lems while higher levels of distress experience might also
lead to higher drug usage levels. Further studies should
use prospective data to identify pathways that connect
family dysfunction, drug use, and psychological distress.
Severity of alcohol use on the other hand was neither a
univariate nor an independent correlate of distress. A
possible reason for this absence of an association could
be lack of variability in alcohol use, since non-use of
alcohol was relatively infrequent in our study.
Gender and marital status, while being significant on the
univariate level, no longer predicted psychological distress
in the multivariate regression analysis. These factors very
likely are associated with some of the other influences,
particularly severity of drug consumption as well as family
functioning. Once these more direct influence factors are
entered into the equation, the more distal indicators loose
relevance. Similarly, perceived stigma was significantly
positively related to distress in the bivariate analysis, but
there was no independent effect in the multivariable
model. Here it is presumably the effect of family function-
ality, which makes a difference, since perception of stigma
might be more likely where SUD patients experience con-
flictual relationships with their families.
Also, somewhat surprisingly, stressful events were un-
related to distress experience. However, it is important
to consider that the study population was already highly
strained group. When being admitted to a treatment
center, many might have had a long past trajectory of
drug abuse, social conflicts or economic problems with
ensuing self worth problems behind them. Singular nega-
tive events might have relatively less to add to distress in
such samples than in average groups of citizens. For such
a highly burdened population group a more detailed as-
sessment than the dichotomous question used in the
present study might have generated different results.
Thus, Liao et al. in a study with patients treated for heroin
dependence in China used a detailed life event rating
scale, explicitly listing different types of events, and found
significant associations with anxiety and depression [43].
Strengths and limitations
This is one of the few studies, which surveyed psychological
distress symptoms among patients with SUD in Nepal.
Data were collected using standardized instruments, which
strengthened the reliability of the collected data. However,
several limitations of this study should be considered. First,
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the analyses were conducted with cross-sectional data and
thus, no causal statements could be made. Secondly, data
in our study were based on self-report and no clinical
assessments or biomarkers, for instance, to investigate the
history of drug and alcohol use in the recent past were in-
cluded. Third, the study was limited by a lack of validation
of the mental health outcome tools within a Nepalese
population. Fourth, as already pointed out above, the
chosen time reference for distress assessment may have led
to overrepresentation of transitorily high distress experi-
ence due to acute crisis, withdrawal symptoms etc. Such a
strong influence of situational effects might also have limi-
ted the possibility to detect associations between patient
characteristics or social influences and distress experience.
A fifth limitation involves sampling bias as the clinics in
the study were conveniently selected and restricted to the
urban Kathmandu valley area in the first place, thus
restricting possibilities to generalize our findings to all sub-
stance users in Nepal. Finally, we did not conduct gender-
specific analyses because it would have involved too small
sub-samples (especially the female sample).
Conclusions
Psychological distress is a serious problem among pa-
tients with SUD in Nepal. Clinicians working with SUD
patients should consider co-morbid psychiatric illness
and therefore this group of population should routinely
be screened for psychiatric co-morbidity. Younger age,
lower levels of education, higher severity of drug abuse
and lower family functionality may be important factors
for psychological distress among SUDs in urban Nepal.
If confirmed by future longitudinal studies such charac-
teristics may assist in identifying groups at risk for co-
morbid psychological distress symptoms among patients
with SUDs. Future treatment approaches for substance
abuse must address co-existing mental illness in Nepal.
If the treatment of substance addiction is limited only to
medical interventions, it is unlikely to attain full effect.
Therefore, an integrated approach to treatment of SUDs,
including supportive educational strategies and interven-
tions to teach coping skills in preventing substance
addiction and psychological distress may be warranted.
However, more research needs to be conducted to sub-
stantiate these findings and to better inform intervention
studies aimed at improving social, behavioral and psy-
chosocial functioning of patients with SUD. Moreover,
longitudinal studies examining the factors associated
with developing psychological distress among patients
with SUD will be helpful in disentangling causal rela-
tions and identifying at an early stage those who are at
risk. Future research should also aim to index the K6-
Scale in the Nepalese populations so that the tool and
current data can be used to adequately estimate popula-
tion prevalence of psychological distress.
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